Malignant mesothelioma with CD30-positivity. A case report and review of the literature.
Abstract
The activation marker CD3O is useful in the diagnosis of Hodgkin and non-Hodgkin lymphomas. It has also been described in nonhematopoietic tumors, including pancreatic carcinomas, salivary gland tumors, and embryonal carcinomas. We report a case of malignant mesothelioma with intense CD30 positivity. This finding has not previously been described and is important in broadening the differential diagnosis of a CD30(+) cohesive large cell malignancy.
我要评论
本期排行
- The challenge of variation in ...
- Pathologic quiz case: recurren...
- Designing tumor marker studies...
- Baron Guillaume Dupuytren.
- Prognostic factors in colorect...
- The oncologic pathology report...
- Pathologic quiz case: abdomina...
- Use of immunohistochemistry to...
- Updated protocol for the exami...
- The total test approach to sta...
共0条评论